The groundbreaking treatment of this peptide represents a significant advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide982503.blogaritma.com/39840979/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment